ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.
cozaar comp forte filmuhúðuð tafla 100/25 mg
n.v. organon* - losartanum kalíum; hydrochlorothiazidum inn - filmuhúðuð tafla - 100/25 mg
cozaar comp filmuhúðuð tafla 50+12,5 mg
n.v. organon* - losartanum kalíum; hydrochlorothiazidum inn - filmuhúðuð tafla - 50+12,5 mg
presmin combo filmuhúðuð tafla 50/12,5 mg
alvogen ehf. - losartanum kalíum; hydrochlorothiazidum inn - filmuhúðuð tafla - 50/12,5 mg
presmin combo filmuhúðuð tafla 100/25 mg
alvogen ehf. - losartanum kalíum; hydrochlorothiazidum inn - filmuhúðuð tafla - 100/25 mg
hydromed tafla 25 mg
medilink a/s - hydrochlorothiazidum inn - tafla - 25 mg
candpress comp tafla 16 mg/12,5 mg
teva b.v.* - candesartanum cílexetíl; hydrochlorothiazide - tafla - 16 mg/12,5 mg
darazíð tafla 20 mg/12,5 mg
actavis group ptc ehf. - enalaprilum maleat; hydrochlorothiazidum inn - tafla - 20 mg/12,5 mg
enalapril comp alvogen (enalapril comp ratiopharm) tafla 20 mg/12,5 mg
alvogen ehf. - enalaprilum maleat; hydrochlorothiazidum inn - tafla - 20 mg/12,5 mg
hydromed tafla 12,5 mg
medilink a/s - hydrochlorothiazidum inn - tafla - 12,5 mg